AstroTalk
has become India’s 133rd unicorn. The startup entered the coveted club after an ESOP buyback valued the platform at $1 Bn. The milestone comes as Astrotalk looks to complement its booming consultation and ecommerce businesses with offline retail and overseas expansion.
The Unicorn Unlock: Unlike many startups that achieve billion-dollar valuations via big-ticket infusions, Astrotalk unlocked its unicorn tag via an internal ESOP liquidity event funded entirely through its operating profits. Over 100 employees participated in the share repurchase at an undisclosed price point.
Inside Astrotalk’s Scale: The ESOP buyback sheds a spotlight on the growing scale of the startup, which last raised capital two years ago at a $300 Mn valuation. Astrotalk claims to have so far served more than 4 Cr users across India and four other countries. Its operating revenue nearly doubled YoY to ₹1,176 Cr in FY25, while net profit rose 2.5X to ₹250 Cr, underscoring strong scale and profitability.
The Ecommerce Engine: To diversify beyond consultations, the platform is now also monetising users by selling items such as gemstones and other religious accessories. The ecommerce vertical, Astrotalk Store, began scaling commercially in January 2025 and generated more than ₹140 Cr in operating revenue during its first year. Since then, the vertical has crossed an ARR of ₹300 Cr, creating a second growth engine for the startup.
The Offline Expansion: Astrotalk is now preparing to take its ecommerce business beyond the digital channel. The startup plans to open its first experiential store in Delhi NCR, while scouting larger-format locations in other cities. It is also developing an international ecommerce website, beginning with the US, to serve the Indian diaspora. The challenge will be converting cultural familiarity into repeat purchases and lasting global brand equity.
As the spiritual tech giant looks to explore ecommerce and offline expansion to sustain its momentum, here is all about Astrotalk entering the coveted unicorn club…
Pharmaceutical companies still run critical commercial workflows on spreadsheets, fragmented systems and manual approvals. This slows tenders, hospital contracts, doctor engagement and distribution decisions. SwishX wants to fix this with its agentic AI stack for the medtech space.
The Pharma Pivot: Founded in 2024, SwishX initially operated in the device leasing space, but the founders later pivoted the business to pharma SaaS. The Bengaluru-based startup is now building an industry-specific intelligence layer for pharmaceutical companies, starting with sales, tenders, hospital contracts and distribution.
SwishX’s Four Engines: SwishX’s platform is organised around four products. Tender IQ identifies relevant government tenders and automates the process. Contract IQ automates hospital negotiations and approvals, while Marketing IQ converts pharma literature into short-form content for healthcare professionals. Channel IQ helps companies manage fragmented retailer and distributor networks.
Why Vertical AI? SwishX uses large language models from Anthropic alongside specialised tools such as Cartesia. The startup claims that it has trained its systems on more than 70,000 Indian pharma tenders and builds customer-specific intelligence inside sandboxed workspaces. Verified sources, human review and compliance controls are central to its approach.
Healthy Early Traction: SwishX claims to have crossed $1 Mn in ARR, works with leading pharmaceutical companies and expects to reach $5 Mn in contracted ARR and more than 100 enterprise customers by FY27. It is already expanding into Brazil, Mexico and Colombia, with longer-term plans to enter other emerging markets. So, can SwishX become the operating system for global pharma?
In the past seven years, Pixxel has managed to put six satellites into Earth’s orbit, raised $96 Mn, landed NASA as a customer, and is now gearing up to launch its next-generation of Honeybee satellites. Here is all about the startup that started as a college project…
Source: Inc42 - Startups
